MEDGENE'S RHDV2 VACCINE GRANTED CRITICAL LICENSE BY USDA'S CENTER FOR VETERINARY BIOLOGICS
The vaccine targeting the lethal Rabbit Hemorrhagic Disease has successfully passed required efficacy and duration-of-immunity testsBROOKINGS, S.D...
Stay updated with breaking news from Gary Bosch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The vaccine targeting the lethal Rabbit Hemorrhagic Disease has successfully passed required efficacy and duration-of-immunity testsBROOKINGS, S.D...
B. Riley to increase its total holdings of bebe to approximately 76% ...
New types of platform vaccines are being created by Medgene in Brookings, South Dakota. These vaccines are able to address specific strains of diseases much quicker than traditional vaccines.
The disease, Rabbit Hemorrhagic Disease Virus Type 2, was first observed in the southwest United States in March of 2020 and has rapidly spread to nearly half of all states.
The disease, Rabbit Hemorrhagic Disease Virus Type 2, was first observed in the southwest United States in March of 2020 and has rapidly spread to nearly half of all states.